Cue Biopharma, Inc.CUENASDAQ
Loading
Debt to Assets Over TimeNormalizing
Percentile Rank60
3Y CAGR-22.3%
5Y CAGR+6.7%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-22.3%/yr
Annual compound
5Y CAGR
+6.7%/yr
Recent deceleration
Percentile
P60
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.10 | -63.9% |
| 2024 | 0.28 | +15.5% |
| 2023 | 0.24 | +12.9% |
| 2022 | 0.21 | +46.8% |
| 2021 | 0.14 | +100.8% |
| 2020 | 0.07 | -11.3% |
| 2019 | 0.08 | - |
| 2018 | 0.00 | -100.0% |
| 2017 | 0.04 | - |
| 2016 | 0.00 | - |